Join us for Episode 22 of NETCast. Mayo Clinical Gastrointestinal Oncologist Dr. Jason Starr interviews Hematologist & Oncologist Dr. Bassam Sonbol about bone marrow toxicity associated with PRRT.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Heloisa Soares is a medical oncologist and Associate Professor at the Huntsman Cancer Institute (HCI) at Universityof Utah. Neuroendocrine tumors and gastrointestinal (GI) cancers are the major focus of her research and clinical activities.

Dr. Soares serves as the Medical Director for the Clinical Trials Office as well as the co-physician leader in the GI Clinical Trials Research Group at HCI. She is a past member of NANETS’ Board of Directors and currently serves as Chair of NANETS’ NETPact Committee.

Dr. Soares is a passionate patient advocate and a Healing NET Foundation Board Member. Along with many patient-centered activities, she volunteers at the ASCO Advocacy Summit on Capital Hill. Dr. Soares is one of our distinguished Guest Discussants on today’s podcast.

Dr. Timothy Hobday is a medical oncologist at the Mayo Clinic Comprehensive Cancer Center. He is a member of the Breast Clinic and Nuclear Medicine Therapy specialty groups. His focus is breast cancer, neuroendocrine tumors, and pancreatic neuroendocrine tumors.

His clinical research is focused on novel targeted therapies for neuroendocrine tumors and breast cancer, contributing significantly to advancements in these fields. His educational background includes a Hematology/Oncology Fellowship and an Internal Medicine Residency, both completed at the Mayo Clinic College of Medicine.

Dr. Hobday is a longtime member of NANETS and a frequent speaker at our conferences and educational programs.

Dr. Virginia Corbett is a medical oncologist at Mount Sinai Medical Center, NYC, where she has been in practice for nine years. Her focus is on liver cancers and neuroendocrine tumors.

She received her MD from Michigan State University- College of Human Medicine and her residency in internal medicine at NY Presbyterian Hospital – Weill Cornell. She completed her residency at Mount Sinai.

Dr. Corbett is a new member of NANETS and currently serves on its Early Career Development Committee. She is today’s Guest Moderator. We welcome her to NETCast!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Join us for Episode 20 of NETCast. Today we are excited to bring a live taping from the NET Regional Education Conference, at U Miami Health and jointly provided by Sylvester Comprehensive Cancer Center and NANETS.

Our guest moderator is Aman Chuahan, MD, is a medical oncologist at University of Miami, Leader of the Neuroendocrine Cancer Program and co-leader of the Diagnostic Drug Development program at Sylvester Comprehensive Cancer Center, and Co-Chair of NANETS Communications Committee.

He is joined by guest participants who attended ENETS and will share some of their impressions:

Jaydira del Rivero, MD, Asst. Research Physician and Director Rare Tumor Clinic, Center for Cancer Research, National Cancer Institute, and member of NANETS’ Executive Board of Directors;

Thorvardur Halfdanarson, MD, Medical Oncology, Associate Professor, Mayo Clinic, President, NANETS Board of Directors; and

Simron Singh, MD, MPH, FRCPC, Medical Oncologist, Odette Cancer Center at Sunnybrook Health Sciences Center, Adjunct Professor, University of Toronto, and Secretary of NANETS’ Board of Directors.

Today’s topic is sure to engage many of you who were unable to attend the ENETS conference, and many of you who will want to tune in to hear about things you may have missed at the conference!

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

In this episode, Dr. Jason Starr. medical oncologist with Mayo Clinic, and Chair of NANETS Communications Committee, talks with NANETS Communications Director Maureen Werther about their goals and projects planned for 2024. Collaboration is the key focal point in '24. Tune in and learn about upcoming webinars, podcasts, programs and events that will be hosted jointly with our partners in the neuroendocrine field.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Simron Singh is a medical oncologist, affiliate scientist in the Odette Cancer Research Program at Sunnybrook Research Institute, and an assistant professor at the University of Toronto. Dr. Singh is a longtime member of NANETS and the current Treasurer of its Board of Directors.

Dr. Alexandria T. Phan is a Professor of Internal Medicine and Medical Oncology at Froedtert & Medical College of Wisconsin, with a special focus on neuroendocrine tumors and malignancies of the GI tract. Dr. Phan is a member of NANETS' Communications and the moderator of this discussion. The doctors will discuss highlights from the recent ASCO meeting, with a special focus on the results of the phase 3 randomized NETTER-2 study. This is the first randomized study to demonstrate efficacy of RLT as 1L treatment in any malignancy and will change clinical practice.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

NET medical professionals gathered in Detroit in November 2023 to discuss highlights from NANETS' 2023 Multidisciplinary NET Medical Symposium held the previous month in Montreal. Internationally renowned cancer researcher and medical oncologist, Philip A. Philip, MD, PhD, Wayne State University, moderated a discussion with fellow NET medical professionals: Jonathan Strosberg, MD, who leads Moffitt’s Neuroendocrine Tumor Division and Department of Gastrointestinal Oncology Research Program; and Amr Mohamed, MD, Director of the Neuroendocrine Tumor Program at University Hospitals Seidman Cancer Center. Topics included surgical treatment for G3 NENs, ongoing and recently completed clinical trials that have the potential to change the current landscape for NENs, and more cutting-edge topics.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Here’s the latest episode of NETCast, recorded live at #NANETS 2023 Symposium in Montreal. Guest moderator, Dr. David Zhen, GI, Medical Oncology, Fred Hutchinson Cancer Center, is joined by Dr. Jennifer Eads, MD, Medical Oncology, Penn Medicine, Dr. Jennifer Chan, Medical Oncology, Dana-Farber Cancer Institute, and Josh Mailman,fierce patient advocate and President of the NET advocacy group NorCal CarciNET for an eye-opening conversation about ongoing/upcoming clinical trials, challenges facing both investigators and patients for NET clinical trials, and most importantly, implications for patients.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.

Dr. Gaby Gabriel, Associate Professor of Radiology and Surgery at U. of Kentucky, and member, NANETS Communications Committee, is our guest moderator for this commonly encountered management decision in NETs. He is joined by a distinguished panel of guest discussants: Dr. Callisia Clarke, Surgical Oncology, Medical College of Wisconsin; Dr. Nicholas Fidelman, Interventional Radiology, UCSF; and Dr. Michael Soulen, Interventional Radiology, Penn Medicine.

See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.